|
Volumn 39, Issue 3, 2007, Pages 622-624
|
Cytomegalovirus Infections in Cardiac Transplant Patients: An Experience at a Clinical Hospital, University of Chile
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
AZATHIOPRINE;
COTRIMOXAZOLE;
CYCLOSPORIN;
DACLIZUMAB;
FLUCONAZOLE;
GANCICLOVIR;
ISONIAZID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
THYMOCYTE ANTIBODY;
VALGANCICLOVIR;
ADOLESCENT;
ADULT;
ARTICLE;
CHILE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLITIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFECT;
DRUG SUBSTITUTION;
FEMALE;
GASTRITIS;
GRAFT FAILURE;
GRAFT INFECTION;
GRAFT REJECTION;
HEART GRAFT;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY GRAFT;
LUNG ASPERGILLOSIS;
MALE;
OUTCOME ASSESSMENT;
PNEUMONIA;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
PROSPECTIVE STUDY;
SIDE EFFECT;
SYMPTOM;
UNIVERSITY HOSPITAL;
ANTIVIRAL AGENTS;
CHILE;
CYTOMEGALOVIRUS INFECTIONS;
HEART TRANSPLANTATION;
HUMANS;
INCIDENCE;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 34147161051
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2006.12.030 Document Type: Article |
Times cited : (6)
|
References (6)
|